Photorealistic aerial view of a sealed glass Venlo greenhouse and processing facility at golden hour on the South African Highveld

PHARMACEUTICAL-GRADECANNABIS.CULTIVATEDINSOUTH AFRICA.ENGINEEREDFOREUROPE.

EU-GMP designed medicinal cannabis cultivation — engineered for the world's lowest cost per gram

A sealed Venlo greenhouse in South Africa, designed from blueprint to EU-GMP and GACP standards, engineered to supply pharmaceutical-grade dried flower to European markets.

Engineered Performance Targets

0.0–0.75/g

Modelled Production Cost

0

Designed Harvest Cycles/Year

0kg

Target Monthly Capacity

0

Designed Plant Capacity

EU-GMP Certification Pathway — designed for compliance from day one

The Highveld Advantage

Why the smartest pharmaceutical distributors are looking at South Africa

Climate Advantage

300+ days of sunshine at the ideal latitude. South Africa's natural conditions reduce energy costs dramatically compared to indoor European cultivation.

Cost Leadership

Modelled production cost of €0.50–0.75/g versus European wholesale at €3–7/g. EU-GMP designed quality standards at a fraction of the cost.

Pharmaceutical Rigour

EU-GMP design compliance. GACP-aligned SOPs. SAHPRA Section 22C licensing pathway. Quality protocols engineered for European pharmaceutical markets from inception.

Reliable Supply

Sealed Venlo greenhouse designed with independent climate zones. Staggered harvesting across six annual cycles engineered for uninterrupted, year-round production.

Regulatory & Partnership Credentials

Targeting European Pharmaceutical Distribution

SAHPRA Licence Pathway

Application Ready

EU-GMP Pathway

Design Compliant

GACP Designed

SOPs Developed to GACP Standards

European Pharmacopoeia

Ph. Eur. Standards

ICH Q7 Guidelines

API Manufacturing

EU Distribution Target

Offtake Discussions Active

UK Import Target

Offtake Discussions Active

SAHPRA Licence Pathway

Application Ready

EU-GMP Pathway

Design Compliant

GACP Designed

SOPs Developed to GACP Standards

European Pharmacopoeia

Ph. Eur. Standards

ICH Q7 Guidelines

API Manufacturing

EU Distribution Target

Offtake Discussions Active

UK Import Target

Offtake Discussions Active

Seed to Shipment

Eight precision-engineered steps from genetics selection to European export

01

Genetics Selection

Sourcing and selecting high-quality cultivars with documented lineage and consistent cannabinoid and terpene profiles.

02

Propagation

Clonal propagation from mother plants ensuring genetic consistency across every production batch.

03

Vegetation

Controlled vegetative growth in a dedicated bay with optimised photoperiod, nutrition, and environmental conditions — all protocol-defined.

04

Flowering

Transfer to independent flowering bays with chemovar-specific light, temperature, and humidity protocols.

05

Harvest

Precisely timed harvest based on trichome maturity assessment and cannabinoid analysis.

06

Drying & Curing

Controlled drying and curing designed to pharmaceutical-grade conditions to preserve terpene profiles and ensure consistent moisture content.

07

Testing & Quality Assurance

Full analytical testing: potency (HPLC), terpene profile (GC), microbial screening, heavy metals, pesticide residue, mycotoxins, and moisture content.

08

Packaging & Export

Pharmaceutical-grade packaging designed to meet EU import requirements, with full batch documentation and Certificate of Analysis.

Photorealistic 3D render of a sealed glass Venlo greenhouse and processing facility at golden hour on the South African Highveld

Facility Design

Pharmaceutical-grade cultivation infrastructure

A sealed glass Venlo greenhouse with independent climate zones, precision environmental controls, and pharmaceutical-grade post-harvest processing. Designed to EU-GMP and GACP standards from inception.

Ready to Explore Pharmaceutical-Grade Cannabis Supply?

Engineered for the world's most competitive cost per gram, designed for European pharmaceutical markets